December 1, 2025 · Form 4 insider transaction
Matsuda Masaru sold 1,657 shares of Arcutis Biotherapeutics, Inc. at $30.23 per share, a transaction worth $50.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on June 5, 2025, by the Reporting Person, with a plan end date of September 4, 2026.; Includes 822 shares acquired under Arcutis Biotherapeutics, Inc. Employee Stock Purchase Plan on November 30, 2025.